GR3017499T3 - Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine. - Google Patents

Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine.

Info

Publication number
GR3017499T3
GR3017499T3 GR950402616T GR950402616T GR3017499T3 GR 3017499 T3 GR3017499 T3 GR 3017499T3 GR 950402616 T GR950402616 T GR 950402616T GR 950402616 T GR950402616 T GR 950402616T GR 3017499 T3 GR3017499 T3 GR 3017499T3
Authority
GR
Greece
Prior art keywords
cysteine
pharmaceutical preparation
carboxymethyl
acetyl
preparation containing
Prior art date
Application number
GR950402616T
Other languages
English (en)
Inventor
Rolf-Dieter Juch
Gerd Dr Birrenbach
Christian Dr Pflugshaupt
Original Assignee
Spirig Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4253965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3017499(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Spirig Ag filed Critical Spirig Ag
Publication of GR3017499T3 publication Critical patent/GR3017499T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR950402616T 1990-10-19 1995-09-21 Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine. GR3017499T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH334590 1990-10-19

Publications (1)

Publication Number Publication Date
GR3017499T3 true GR3017499T3 (en) 1995-12-31

Family

ID=4253965

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402616T GR3017499T3 (en) 1990-10-19 1995-09-21 Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine.

Country Status (7)

Country Link
US (1) US5401514A (el)
EP (1) EP0481294B2 (el)
AT (1) ATE125702T1 (el)
DE (1) DE59106133D1 (el)
DK (1) DK0481294T4 (el)
ES (1) ES2077757T5 (el)
GR (1) GR3017499T3 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
US5807894A (en) * 1992-12-02 1998-09-15 Zambon Group S.P.A. Syrup containing N-acetyl-cysteine
GB9305058D0 (en) * 1993-03-12 1993-04-28 Penn Pharm Ltd Pharmaceutical compositions
SE9601527D0 (sv) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally alministered acetylcysteine as mucolytic agent
EP0839528B1 (en) * 1996-10-29 2001-03-14 Staroil Limited Mouth-soluble compositions containing N-acetylcysteine and cyclodextrin
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
IT1311907B1 (it) * 1999-04-06 2002-03-20 Zambon Spa Compresse deglutibili ad alto contenuto di n-acetilcisteina.
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
WO2002041887A1 (fr) * 2000-11-21 2002-05-30 Kyorin Pharmaceutical Co., Ltd. Preparations seches de sirop
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
CA2500919A1 (en) * 2002-10-04 2004-04-22 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7790928B1 (en) * 2005-04-25 2010-09-07 Albert Raymond Hechinger Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
CN102316730A (zh) * 2008-05-09 2012-01-11 天雅瑞药业有限公司 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
EP2886108B2 (de) * 2013-12-23 2022-11-02 Dr. Falk Pharma Gmbh Optimierte pharmazeutische Formulierung zur Behandlung von entzündlichen Veränderungen des Ösophagus
RU2611411C1 (ru) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка ацетилцистеина и способ ее изготовления
CN108553439B (zh) * 2018-04-20 2020-10-16 广州白云山医药集团股份有限公司白云山制药总厂 一种含s-羧甲基-l-半胱氨酸的肠溶片剂
PH12018000390A1 (en) * 2018-11-20 2020-09-28 Novex Science Pte Ltd Carbocysteine and zinc tablet
US20220175851A1 (en) * 2019-03-13 2022-06-09 The Regents Of The University California Compositions, methods for regulating uterine, placental growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
HU180443B (en) * 1979-04-02 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a pharmaceutical preparation with synergetic action against radiation
NL8502092A (nl) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma Tabletten die s-carboxymethylcysteine bevatten en werkwijze voor de bereiding daarvan.
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (el) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat

Also Published As

Publication number Publication date
DE59106133D1 (de) 1995-09-07
ES2077757T5 (es) 2001-06-01
DK0481294T3 (da) 1995-11-27
EP0481294B1 (de) 1995-08-02
EP0481294A1 (de) 1992-04-22
EP0481294B2 (de) 2001-04-11
DK0481294T4 (da) 2001-06-18
ATE125702T1 (de) 1995-08-15
ES2077757T3 (es) 1995-12-01
US5401514A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
GR3017499T3 (en) Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine.
SE8902288L (sv) Farmaceutisk komposition
DK214689A (da) Farmaceutiske midler
FR2724844B1 (fr) Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
SE8702941L (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
GR3032874T3 (en) Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration
AU2003292006A1 (en) 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
AU5038990A (en) Anti-hiv drug
DE59509928D1 (de) Antihyperglykämisch wirksame Arzneimittel
CA2244357A1 (en) A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
AU6442590A (en) Device for oral administration of an active principle for preventive treatment of caries in babies
ATE210428T1 (de) Geschmacksmaskierte wässrige lösungen enthaltend ibuprofen und menthol
GR3019176T3 (en) Medicament containing a combination of AZT and amantadin for the treatment of AIDS.
CA2122478A1 (en) Unit Dose Form of Bismuth Subsalicylate
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.
ES8706028A1 (es) Procedimiento de preparacion de nuevas composiciones sinergeticas antimicrobianas que contienen aritetraciclina y un acido organico de acitividad antimicrobiana.
RU92015628A (ru) Состав для дезинфекции объектов пчеловодства
RU98105696A (ru) Средство для лечения и профилактики болезней полости рта
GB2213062A (en) Pharmaceutical preparation having oestrogen action
AU8640491A (en) Device for administering a physiologically active substance to the gastro-intestinal tract